Copy to clipboard 
Fried Vancraen, CEO of Materialise, provider of Additive Manufacturing software and solutions in the medical market, calls upon industry stakeholders to come to an agreement for a common standard for measuring the clinical, economical and patient benefits of medical 3D printing in delivering better patient outcomes. Materialise will lead this ongoing initiative as the founding sponsor of the Building Evidence for 3D Printing Applications in Medicine event hosted by SME, following the RAPID Conference, an annual 3D printing and additive manufacturing event, May 19-20 in Orlando, Florida.
“There have been several initiatives aimed at properly measuring and validating the clinical benefits of medical 3D Printing, but all have suffered from a lack of coordination and agreed-upon research methodologies,” says Vancraen. “The fact is, we can only be successful if we take an evidence-based approach across the industry, acting in concert with a set of protocols, methodologies and measurement guidelines. With the proper scientific rigor, our ambition of gaining widespread acceptance of medical 3D Printing will be realized more swiftly, and the patients whom we aim to serve will benefit the most.”
For more information, please visit this link.
Source: Materialise
BONEZONE is also a sponsor of the Building Evidence for 3D Printing Applications in Medicine event. Here is a recap from the event.
